NCT00643799 - Safety and Efficacy of Celecoxib Versus Naproxen in the 6-month Treatment of Knee Osteoarthritis | Biotech Hunter

Enrollment

586

Participants

Timeline

Start Date

March 31, 2004

Primary Completion Date

January 31, 2005

Study Completion Date

January 31, 2005

Conditions

Osteoarthritis, Knee

Interventions

DRUG

Celecoxib

200 mg oral capsule once daily for 6 months

DRUG

Naproxen

500 mg oral capsule twice daily for 6 months

DRUG

Placebo

Matched oral placebo for 6 months

Trial Locations (51)

10022

Pfizer Investigational Site, New York

16635

Pfizer Investigational Site, Duncansville

18015

Pfizer Investigational Site, Bethlehem

19603

Pfizer Investigational Site, Media

20006

Pfizer Investigational Site, Washington D.C.

20735

Pfizer Investigational Site, Clinton

20770

Pfizer Investigational Site, Greenbelt

20902

Pfizer Investigational Site, Wheaton

21740

Pfizer Investigational Site, Hagerstown

32204

Pfizer Investigational Site, Jacksonville

32720

Pfizer Investigational Site, DeLand

32804

Pfizer Investigational Site, Orlando

33024

Pfizer Investigational Site, Pembroke Pines

33186

Pfizer Investigational Site, Miami

33542

Pfizer Investigational Site, Zephyrhills

33614

Pfizer Investigational Site, Tampa

33761

Pfizer Investigational Site, Clearwater

34474

Pfizer Investigational Site, Ocala

36106

Pfizer Investigational Site, Montgomery

39232

Pfizer Investigational Site, Flowood

40503

Pfizer Investigational Site, Lexington

40515

Pfizer Investigational Site, Lexington

43124

Pfizer Investigational Site, Columbus

43215

Pfizer Investigational Site, Columbus

43222

Pfizer Investigational Site, Columbus

44122

Pfizer Investigational Site, Beachwood

48910

Pfizer Investigational Site, Lansing

61103

Pfizer Investigational Site, Rockford

64114

Pfizer Investigational Site, Kansas City

67207

Pfizer Investigational Site, Wichita

67212

Pfizer Investigational Site, Wichita

68506

Pfizer Investigational Site, Lincoln

68516

Pfizer Investigational Site, Lincoln

70006

Pfizer Investigational Site, Metairie

70433

Pfizer Investigational Site, Covington

73103

Pfizer Investigational Site, Oklahoma City

75235

Pfizer Investigational Site, Dallas

76904

Pfizer Investigational Site, San Angelo

78705

Pfizer Investigational Site, Austin

80230

Pfizer Investigational Site, Denver

84109

Pfizer Investigational Site, Salt Lake City

84121

Pfizer Investigational Site, Salt Lake City

85014

Pfizer Investigational Site, Phoenix

85282

Pfizer Investigational Site, Tempe

90620

Pfizer Investigational Site, Buena Park

90723

Pfizer Investigational Site, Paramount

92103

Pfizer Investigational Site, San Diego

92108

Pfizer Investigational Site, San Diego

92270

Pfizer Investigational Site, Rancho Mirage

01757

Pfizer Investigational Site, Milford

02886

Pfizer Investigational Site, Warwick

All Listed Sponsors

lead

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

INDUSTRY